Dr Reddy's launches generic hypotensive injection in US

Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.

The company has launched generic Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Labs said in a filing to the BSE.

The product is a generic version of Hospira Inc's Nitropress injection, 50 mg/2ml, it added. As per IQVIA Health data, Nitropress brand and generics had US sales of around $8 million MAT for the twelve months to October 2019, Dr Reddy's said.

Sodium Nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises.